article thumbnail

Prescribing ADHD Meds by Telehealth Does Not Alter Risk for Substance Use Disorder Overall

Physician's Weekly

TUESDAY, June 17, 2025 (HealthDay News) — Receipt of a stimulant prescription for attention-deficit/hyperactivity disorder (ADHD) via telehealth is not associated with an increased risk for substance use disorder (SUD), according to a study published online June 11 in The American Journal of Psychiatry. Vinod Rao, M.D.,

article thumbnail

Endocrinology, Diabetes and Metabolism Board Meeting Summary | Spring 2025

ABIM

Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Plenary Abstracts at AAHPM/HPNA: Yael Schenker, Na Ouyang, Marie Bakitas

GeriPal

Marie 16:30 I actually don’t think it matters if you can establish rapport and if you do good telehealth etiquette, which is seeing who else is in the room, addressing everybody that was there, et cetera. When you say telehealth, you mean like video health, like so they could see each other? Would you do it again?

article thumbnail

PC for Patients with Substance Use Disorder: Janet Ho, Sach Kale, Julie Childers

GeriPal

Alex 10:49 And then when you say accountability without termination, that sounds like it speaks to a core principle of palliative care around non abandonment and building relationships. Widera and Smith have no relationships to disclose. Guests Janet Ho, Sach Kale, Julie Childers have no relationships to disclose.